VivArt-X is a biotechnology startup founded in 2022, with a focus on the development of regenerative materials for Women's Health. The company recently secured a €660.00KPre Seed Round investment from notable investors including Brabant Startup Fund, Eindhoven University of Technology, BOM on 16 November 2023. This injection of capital will likely bolster their research and development efforts, potentially accelerating their progress towards bringing innovative solutions to market.
General Information
Get notified when VivArt-X moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track VivArt-X
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Biotechnology
About VivArt-X
Taxonomy: regenerative materials, women's health, regenerative medicine
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Pre Seed Round - VivArt | €660.00K | 3 | Brabant Startup Fund, Eindhoven University of Technology +1 | 16 Nov 2023 |
VivArt-X Alternatives & Competitors
Biomaterials, reimagined.
Regenerating agriculture, cities, and communities.
Synova Life Sciences is a privately-owned biotechnology company that develops medical devices and me...
FAQ About VivArt-X
Don't just browse. Track.
Signal Tracker monitors VivArt-X and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.